You are subscribed to the FormularyWatch.

Formulary

eNewsletter Subscribe

February 11, 2014

Web Version  |  Share with a colleague

Facebook Like   Twitter Tweet

Today's Headlines

Stroke guidelines specifically for women

For the first time, guidelines have been developed for preventing stroke in women. » Full article

Tobacco ban: Will others follow CVS?

An interdisciplinary group of pharmacists, pharmacy school and medical school faculty, pharmacy students, nurses, physicians, attorneys, and health advocates have called on Walgreens and Rite Aid to join CVS Caremark and stop the sale of tobacco products in their stores. » Full article

Continuing Education

New CPE series: MTM Considerations for Adult Patients with CVD

Drug Topics kicks off a new CPE series, MTM Considerations for Adult Patients with Cardiovascular Disease, which will include 12 knowledge-based activities worth up to 24 credits. The goal of the first activity, “MTM essentials for cholesterol management,” will empower pharmacists to utilize current understanding of cholesterol management to improve patient care. To read and print the article with TEST QUESTIONS, click here. To proceed to the online exams and earn up to 2 CPE credits, click here to log in.


Announcement: Welcome to the new user registration process. This new process requires all pharmacists and pharmacy technicians to provide or update their NABP e-Profile ID in order to electronically keep track of CPE credits from ACPE-accredited providers. If you have not done so, you can obtain your NABP e-Profile ID now at www.MyCPEmonitor.net. This profile will enable you to have one login for all the NABP programs and services you will need throughout your career.

EDITOR'S PICK

Newest FDA drug approvals

Actions in brief, complete response letters, breakthrough therapy designation, fast-track designations, orphan drug designations. » Full article

 

Related Articles

Dietary fiber lowers risk of first stroke: Study

CVS Caremark will drop tobacco products in October

RESOURCES

Drug Watch

Latest Clinical News

 
Powered by Modern Medicine Advanstar Medical Communications Group